Innovations_Digital wins iCARE Clinics account
iCARE Clinics – the new healthcare venture from Landmark Group have entrusted Innovations_Digital with the entire through-the-line marketing portfolio. Innovations started with the identity development project for the newly formed healthcare division at Landmark (under the label of Excel Healthcare LLC), and was then given the commission for the online projects including the website development, social media and search initiatives.
Innovations_Digital will also work with iCARE as the Agency of Record on all their advertising and marketing initiatives including developing their outdoor media, signage, livery, and in-clinic identity applications. A launch campaign is being developed for the series of clinics being purpose-designed across Dubai (Oasis Centre, Tecom and Discovery Gardens, to start with).
The iCARE venture at Landmark is being spearheaded by Anuraag Malhotra, who is also the top legal eagle at Landmark. Rahul Jagtiani heads up the marketing effort for iCARE amongst his other portfolios at Landmark, and Dr Atul Aundhekar is the Chief Medical Officer with the group. From the beginning, Innovations were clearly briefed by the iCARE team about the clinics’ “totally different go-to-market strategies” – which included a position that highlighted integrity, transparency, affordability and genuine quality amongst other key differentiating factors in a fairly over-crowded market.
Innovations_Digital is a leading digital agency in Dubai that works closely with client partners to harness the power of digital and emerging media to develop conversations and communications for brands across online, mobile, outdoor and social media. Together with the iCARE management and marketing team, Innovations_Digital will work towards developing relationships with customers, starting with conversations in social media (iCARE is on facebook) and in working towards making the in-clinic experience something that is genuinely holistic and promising. The iCARE website is under construction.
You can follow any responses to this entry through the RSS feed. You can leave a response, or trackback from your own site.
